Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-04-24

Clinical Trial Update: Study of Imiquimod 5% Cream in Addition to Cryotherapy in the Management of Actinic Keratoses [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether adding imiquimod 5% cream to cryotherapy improves management of actinic keratosis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Imiquimod 5% cream (Imiquimod)

Snippet

Sponsor: Derm Research @ 888 Inc. | Conditions: Keratosis, Actinic Keratosis | Phase 4 | Status: COMPLETED